Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

StackMD vs Vital Edge

StackMD
Graded #259

Lower grade

vs+1.6000000000000014
Vital Edge
Graded #235

Higher grade

The verdict

Vital Edge takes it — 65/100 to 63.4/100, but only just.

Vital Edge grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vital Edge is a Chattanooga, TN telehealth practice offering physician-supervised GLP-1 weight loss nationwide by video, with medication shipped to your door each month. StackMD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueStackMD +9
46
37
Dose & formulationVital Edge +34
54
88
Clinical oversightVital Edge +8
78
86
Labs & monitoringStackMD +9
62
53
FulfillmentStackMD +17
89
72
Contract termsStackMD +14
69
55
StackMD · left barVital Edge · right bar

The numbers

MetricStackMDVital Edge
WeighScore63.4/10065/100
GradeCC
Scorecard rank#259#235
Semaglutide$125/mo (1 mg dose, plus a separate fee, compounded)$350/mo (compounded)
Tirzepatide$199/mo (5 mg dose, compounded)$450/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
StackMD

Graded #259 · C

Strengths

  • Publishes an exact price for every dose strength rather than a single 'from' figure — semaglutide $125-$225, tirzepatide $199-$449
  • Names both its legal entity (Medical 360 HC PLLC) and its prescribing telehealth partner, SamaritanMD
  • No membership or platform fee — the medication price is the whole price
  • States plainly that its compounded medications are 'not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
  • Telehealth offered in all 50 states per its terms, with free discreet shipping and FSA/HSA eligibility

Where it loses points

  • All sales are final — 'No refunds are issued except as described below', and dispensed medication cannot be returned
  • Compounding pharmacies are never named, only 'a licensed third-party pharmacy'
  • Price rises steeply with dose: tirzepatide runs $199 at 5mg to $449 at 30mg
  • Billing and refunds are handled by SamaritanMD — StackMD 'has no authority to issue refunds' on its behalf
  • Terms impose binding arbitration in New York and waive jury trial and class-action participation
Vital Edge

Graded #235 · C

Strengths

  • Transparent flat monthly pricing published on-site — consult, medication, and shipping all included
  • Broad menu: compounded semaglutide/tirzepatide, compounded oral capsules from $199/mo, plus brand-name Ozempic, Wegovy, Mounjaro and Rybelsus
  • LegitScript-certified (seal #43281221)
  • Flat fee with no upcharge as your dose increases
  • Compounded oral GLP-1 capsules available for needle-free dosing

Where it loses points

  • Compounded injectable pricing ($350 semaglutide / $450 tirzepatide) runs above the lowest-cost telehealth options
  • No compounding pharmacy partner named on the site
  • No named medical director or prescribing clinicians
  • State availability not published — only a nationwide virtual-care claim
  • Small, locally-rooted operation with a limited public track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard